Skip to main content
International Journal of Nephrology and Renovascular Disease logoLink to International Journal of Nephrology and Renovascular Disease
. 2021 Mar 3;14:65. doi: 10.2147/IJNRD.S308249

Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]

PMCID: PMC7937392  PMID: 33688236

Hinz M, Stein A, Uncini T. Int J Nephrol Renovasc Dis. 2011;4:101–113.

The Editor-in-chief and Publisher of International Journal of Nephrology and Renovascular Disease wish to retract the published article.

This review article cites several original research articles published by the authors, which have recently been retracted. This article draws on the findings from those original research articles to form central arguments and discussion, and as a result of the research articles’ retraction, the argument presented in this article is no longer valid and the editor has determined it should be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


Articles from International Journal of Nephrology and Renovascular Disease are provided here courtesy of Dove Press

RESOURCES